<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2023.1102862</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The effects of camelina sativa oil and high-intensity interval training on liver function and metabolic outcomes in male type 2 diabetic rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kavyani</surname>
<given-names>Zeynab</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dehghan</surname>
<given-names>Parvin</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1614216/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khani</surname>
<given-names>Mostafa</given-names>
</name>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2143429/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khalafi</surname>
<given-names>Mousa</given-names>
</name>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1540522/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosenkranz</surname>
<given-names>Sara K.</given-names>
</name>
<xref rid="aff6" ref-type="aff"><sup>6</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Student Research Committee, Tabriz University of Medical Sciences</institution>, <addr-line>Tabriz</addr-line>, <country>Iran</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Biochemistry and Nutrition Therapy, School of Nutrition and Food Science, Tabriz University of Medical Sciences</institution>, <addr-line>Tabriz</addr-line>, <country>Iran</country></aff>
<aff id="aff3"><sup>3</sup><institution>Nutrition Research Center, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences</institution>, <addr-line>Tabriz</addr-line>, <country>Iran</country></aff>
<aff id="aff4"><sup>4</sup><institution>Faculty of Physical Education and Sport Sciences, University of Tabriz</institution>, <addr-line>Tabriz</addr-line>, <country>Iran</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Physical Education and Sport Sciences, Faculty of Humanities, University of Kashan</institution>, <addr-line>Kashan</addr-line>, <country>Iran</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Kinesiology and Nutrition Sciences, University of Nevada Las Vegas</institution>, <addr-line>Las Vegas, NV</addr-line>, <country>United States</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by"><p>Edited by: Daniel Machin, Florida State University, United States</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Reviewed by: Naheed Aryaeian, Iran University of Medical Sciences, Iran; Pamela Senesi, University of Milan, Italy; Fatemeh Naeini, Tehran University of Medical Sciences, Iran</p></fn>
<corresp id="c001">&#x002A;Correspondence: Parvin Dehghan, <email>Dehghanp@tbzmed.ac.ir</email></corresp>
<fn id="fn0003" fn-type="other"><p>This article was submitted to Sport and Exercise Nutrition, a section of the journal Frontiers in Nutrition</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1102862</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Kavyani, Dehghan, Khani, Khalafi and Rosenkranz.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Kavyani, Dehghan, Khani, Khalafi and Rosenkranz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>The purpose of this study was to evaluate the independent and combined effects of camelina sativa oil and high-intensity interval training (HIIT) on liver function, and metabolic outcomes in streptozotocin-induced diabetic rats.</p>
</sec>
<sec>
<title>Methods</title>
<p>Forty male Wistar rats were randomly assigned to five equal groups (8 per group): Normal control (NC), diabetic control (DC), diabetic&#x2009;+&#x2009;camelina sativa oil (300&#x2009;mg/kg by oral gavage per day; D&#x2009;+&#x2009;CSO), diabetic&#x2009;+&#x2009;HIIT (running on a treadmill 5&#x2009;days/week for 8&#x2009;weeks; D&#x2009;+&#x2009;HIIT), diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT (D&#x2009;+&#x2009;CSO&#x2009;+&#x2009; HIIT).</p>
</sec>
<sec>
<title>Results</title>
<p>In all three intervention groups (D + CSO, D + HIIT, and D + CSO + HIIT) compared to the DC, hepatic TNF-&#x03B1;, MDA, and histopathology markers, decreased and hepatic PGC-1&#x03B1;, and PPAR-&#x03B3; increased (p &#x003C; 0.05). However, the effect of D&#x2009;+&#x2009;CSO was greater than D&#x2009;+&#x2009;HIIT alone. Hepatic TG decreased significantly in D&#x2009;+&#x2009;HIIT and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT compared to other groups (<italic>p</italic> &#x003C;&#x2009;0.001). Fasting plasma glucose in all three intervention groups (D&#x2009;+&#x2009;CSO, D&#x2009;+&#x2009;HIIT, and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT) and HOMA-IR in D&#x2009;+&#x2009;CSO and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT were decreased compared to DC (<italic>p</italic> &#x003C;&#x2009;0.001). Only hepatic TAC and fasting plasma insulin remained unaffected in the three diabetic groups (<italic>p</italic> &#x003C;&#x2009;0.001). Overall, D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT had the largest effect on all outcomes.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>At the doses and treatment duration used in the current study, combination of CSO and HIIT was beneficial for reducing liver function and metabolic outcomes other than CSO and HIIT alone.</p>
</sec>
</abstract>
<kwd-group>
<kwd>camelina oil</kwd>
<kwd>high-intensity interval training</kwd>
<kwd>diabetes</kwd>
<kwd>inflammation and oxidative stress</kwd>
<kwd>hepatic steatosis</kwd>
</kwd-group>
<contract-num rid="cn1">38760</contract-num>
<contract-sponsor id="cn1">Vice-chancellor for Research and Student Research Committee of Tabriz University of Medical Sciences, Tabriz, Iran</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="1"/>
<ref-count count="81"/>
<page-count count="10"/>
<word-count count="8150"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>Type 2 diabetes mellitus (T2DM) is a long-term endocrine disease characterized by hyperglycemia and is associated with inflammation, oxidative stress; insulin resistance (IR), and hepatic steatosis (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). There is emerging evidence that chronic hyperglycemia <italic>via</italic> dysregulated production of tumor necrosis factor-alpha (TNF-&#x03B1;), <italic>interleukin 6</italic> (IL-6), and C-reactive protein (CRP), along with excess free radical production and oxidative stress, plays a critical role in the development of IR and T2DM (<xref ref-type="bibr" rid="ref3">3</xref>). Furthermore, diabetic patients have an increased risk of liver disease and liver failure, which is one of the most common causes of death in diabetic patients (<xref ref-type="bibr" rid="ref4">4</xref>). Impaired liver function is caused by IR, oxidative stress, and inflammation in the tissue organ, and in patients with T2DM, is partly due to elevated blood glucose levels (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). In addition, previous research has indicated a strong association between liver fat accumulation and T2DM, indicating an increased risk for nonalcoholic fatty liver disease (<xref ref-type="bibr" rid="ref7">7</xref>). Therefore, the prevention of inflammation and oxidative stress leading to liver fat accumulation are therapeutic targets in patients with T2DM. Numerous studies have confirmed that consumption of omega-3 fatty acids improves both macro and micro-vascular complications of T2DM by modifying the gut microbiota (<xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref8">8</xref>) and controlling IR (<xref ref-type="bibr" rid="ref9">9</xref>&#x2013;<xref ref-type="bibr" rid="ref12">12</xref>), oxidative stress (<xref ref-type="bibr" rid="ref13">13</xref>), inflammation (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>), lipid metabolism (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>), and hepatic fat deposition (<xref ref-type="bibr" rid="ref18">18</xref>). Recently, due to current concerns about heavy metal-contaminated fish oil supplements and their adverse effects, switching omega-3 fatty acids sources from animal to plant sources has been considered (<xref ref-type="bibr" rid="ref19">19</xref>). Camelina sativa, known as false flax, is one of the richest food sources of omega-3 fatty acids, with polyunsaturated fatty acid (PUFA) values of more than 50%, alpha-linolenic acid (ALA) 40%&#x2013;45%, as well as high content of phytosterols (331&#x2013;442&#x2009;mg/100&#x2009;g), carotenoids (103&#x2013;198&#x2009;mg/of carotene/kg), and tocopherols (55.8&#x2013;76.1&#x2009;mg/100&#x2009;g) (<xref ref-type="bibr" rid="ref20">20</xref>). According to the evidence provided by the FDA and the study conducted by Mousazadeh et al. (<xref ref-type="bibr" rid="ref21">21</xref>), side effects have not been reported, but due to the high dose of omega-3 (more than 3&#x2009;g/day), it may have gastrointestinal effects, so caution should be used in the prescription of high doses of camelina oil (<xref ref-type="bibr" rid="ref22">22</xref>). Allong with nutrient intake (<xref ref-type="bibr" rid="ref5">5</xref>), exercise training is an effective intervention for the treatment and prevention of metabolic disorders such as T2DM (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). The effects of exercise training are associated with increased expression or activity of proteins involved in insulin signaling, subsequently modulating glycogen synthase activity, glucose transporter expression in the muscle, and improving IR, inflammation, and oxidative stress in T2DM patients (<xref ref-type="bibr" rid="ref25">25</xref>). In a study, the benefits of strength exercise have been shown in reducing hepatic triglyceride content among T2DM rats (<xref ref-type="bibr" rid="ref26">26</xref>). Traditionally, moderate-intensity continuous training has been considered an effective method of training for improving health outcomes in T2DM patients; however, high-intensity interval training (HIIT) is a well-accepted alternative strategy that may serve as a way for some individuals to save time (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
<p>Peroxisome proliferator-activated receptor gamma (PPAR-&#x03B3;) controls fatty acid, glucose, and inflammatory processes (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). PPAR-&#x03B3; agonists directly activate liver glucose-sensing genes, improving glucose homeostasis and insulin sensitivity in T2DM patients (<xref ref-type="bibr" rid="ref30">30</xref>). Omega-3 fatty acids and exercise upregulate PPAR-&#x03B3; coactivator 1&#x03B1; (PGC-1&#x03B1;), which regulates mitochondrial biogenesis and activates PPAR-&#x03B3; (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). HIIT is an effective approach for reducing lipogenesis (<xref ref-type="bibr" rid="ref33">33</xref>) and improving inflammation (<xref ref-type="bibr" rid="ref34">34</xref>), IR, postprandial glycemia (<xref ref-type="bibr" rid="ref35">35</xref>) fat loss (<xref ref-type="bibr" rid="ref36">36</xref>), visceral fat and liver fat (<xref ref-type="bibr" rid="ref37">37</xref>) which are all important treatment targets for patients with T2DM. To the best of our knowledge, there is no study investigating the simultaneous effects of CSO intake and HIIT on liver function, the status of inflammation, oxidative stress, and lipogenesis. The current intervention study aimed to examine to determine the independent and combined effects of camelina sativa oil and HIIT on liver function, and metabolic outcomes in male T2DM rats. We hypothesized that the combination of both would provide superior benefits for reducing inflammation, oxidative stress and lipogenesis, as well as liver triglycerides.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec3">
<title>Ethics statement</title>
<p>All animal experiments were carried out in accordance with the National Institutes of Health&#x2019;s ethical standards for the care and use of laboratory animals (NIH; Publication No. 85-23, revised 1985), which were examined and confirmed by the Veterinary Ethics Committee of Tabriz University of Medical Sciences (Approval No.: IR.TBZMED.AEC.1401.040).</p>
</sec>
<sec id="sec4">
<title>Experimental design</title>
<p>Forty (3-month-old) adult male Wistar rats (225&#x2013;300&#x2009;g), were obtained from the Central Animal House, Tehran University of Medical Sciences, and adapted to the experimental conditions in standard polypropylene cages (4 rats/cage) under controlled humidity (50&#x2009;&#x00B1;&#x2009;5%) and temperature (20&#x2009;&#x00B1;&#x2009;2&#x00B0;C) with a 12&#x2009;h light/dark cycle for 2&#x2009;weeks. T2DM was induced through a combination of a high-fat diet (HFD) and a single dose of Streptozotocin (STZ; 35&#x2009;mg/kg, intraperitoneal (ip) 0.1&#x2009;M citrate buffer, pH 4.5) after rats have fasted for 5&#x2009;h. Rats were fed with a high-fat diet (45% fat, 34% carbohydrate, and 21% protein) prepared from animal tail oil (450&#x2009;g per 100&#x2009;g standard pellet) and cholesterol gel for an initial period of 2&#x2009;weeks and then injected intraperitoneally with a single dose of streptozotocin (STZ, 35&#x2009;mg/kg of body weight), which was freshly prepared by dissolving in 0.1&#x2009;M citrate buffer (pH 4.5). A week after induction of T2DM, the rats with blood glucose levels of 250&#x2009;mg/dL or greater were considered diabetic (<xref ref-type="bibr" rid="ref38">38</xref>). Blood glucose levels were measured by a glucometer from the tail vein of animals after a 12&#x2009;h fast following the 2-week high-fat diet. Animals had access to <italic>ad libitum</italic> water and standard chow (54% carbohydrate, 26% protein, 13% fat, 5% fiber, and 3% vitamins, and minerals). Rats were randomly allocated into five groups (8 per group, calculated using G&#x002A;Power) including 1-Normal control (NC) was given normal saline by oral gavage; 2-Diabetic control (DC) was given normal saline by oral gavage; 3-Diabetic&#x2009;+&#x2009;camelina sativa oil (300&#x2009;mg/kg) by oral gavage (D&#x2009;+&#x2009;CSO), 4-Diabetic&#x2009;+&#x2009;HIIT (D&#x2009;+&#x2009;HIIT) were given normal saline by oral gavage, and 5-Diabetic + camelina sativa oil (300&#x2009;mg/kg) by oral gavage&#x2009;+&#x2009;HIIT (D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT) (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Experimental design. HIIT, High-intensity interval training.</p>
</caption>
<graphic xlink:href="fnut-10-1102862-g001.tif"/>
</fig>
</sec>
<sec id="sec5">
<title>Camelina oil supplementation</title>
<p>We used a gas chromatograph to analyze the fatty acid composition of CSO (Bistun Shafa Co, Kermanshah, Iran). The study&#x2019;s CSO analysis showed that the highest fatty acids were linolenic acid (29.70%), linoleic acid (21.03%), and oleic acid (16.41%; <xref rid="tab1" ref-type="table">Table 1</xref>; <xref ref-type="bibr" rid="ref39">39</xref>). According to the evidence provided by the FDA, CSO has been deemed to be generally safe, and is registered as food oil in many European nations. Rats in the CSO conditions were fed by oral gavage based on weight at a dose of 300&#x2009;mg/kg per day for 8&#x2009;weeks. Rats in the non-CSO groups were given saline, % 0.9 NaCl, <italic>via</italic> oral gavage (1&#x2009;mL per day). Oral gavages were performed before exercise in the HIIT conditions (<xref ref-type="bibr" rid="ref40">40</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Composition of fatty acids present in camelina sativa oil.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Fat</th>
<th align="left" valign="top">%</th>
<th align="left" valign="top">Fatty acid</th>
<th align="left" valign="top">Name</th>
<th align="center" valign="top">Camelina oil (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="8">SFA</td>
<td align="char" valign="top" char="." rowspan="8">13.82</td>
<td align="left" valign="top">C12:0</td>
<td align="left" valign="top">Lauric acid</td>
<td align="char" valign="top" char=".">0.00</td>
</tr>
<tr>
<td align="left" valign="top">C14:0</td>
<td align="left" valign="top">Myristic acid</td>
<td align="char" valign="top" char=".">0.09</td>
</tr>
<tr>
<td align="left" valign="top">C16:0</td>
<td align="left" valign="top">Palmitic acid</td>
<td align="char" valign="top" char=".">6.45</td>
</tr>
<tr>
<td align="left" valign="top">C18:0</td>
<td align="left" valign="top">Stearic acid</td>
<td align="char" valign="top" char=".">2.56</td>
</tr>
<tr>
<td align="left" valign="top">C20:0</td>
<td align="left" valign="top">Arashidic acid</td>
<td align="char" valign="top" char=".">1.89</td>
</tr>
<tr>
<td align="left" valign="top">C21:0</td>
<td align="left" valign="top">Heneicosanoic acid</td>
<td align="char" valign="top" char=".">1.66</td>
</tr>
<tr>
<td align="left" valign="top">C22:0</td>
<td align="left" valign="top">Behenic acid</td>
<td align="char" valign="top" char=".">1.00</td>
</tr>
<tr>
<td align="left" valign="top">C24:0</td>
<td align="left" valign="top">Lignoseric acid</td>
<td align="char" valign="top" char=".">0.17</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="5">MUFA</td>
<td align="char" valign="top" char="." rowspan="5">34.36</td>
<td align="left" valign="top">C16:0</td>
<td align="left" valign="top">Palmitoleic acid</td>
<td align="char" valign="top" char=".">0.17</td>
</tr>
<tr>
<td align="left" valign="top">C18:0</td>
<td align="left" valign="top">Oleic acid</td>
<td align="char" valign="top" char=".">16.41</td>
</tr>
<tr>
<td align="left" valign="top">C20:0</td>
<td align="left" valign="top">Elcosenoic acid</td>
<td align="char" valign="top" char=".">14.09</td>
</tr>
<tr>
<td align="left" valign="top">C22:0</td>
<td align="left" valign="top">Erucic acid</td>
<td align="char" valign="top" char=".">3.21</td>
</tr>
<tr>
<td align="left" valign="top">C24:0</td>
<td align="left" valign="top">Nervonic acid</td>
<td align="char" valign="top" char=".">0.47</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="4">PUFA</td>
<td align="char" valign="top" char="." rowspan="4">51.83</td>
<td align="left" valign="top">C18:0</td>
<td align="left" valign="top">Linoleic acid</td>
<td align="char" valign="top" char=".">21.03</td>
</tr>
<tr>
<td align="left" valign="top">C18:0</td>
<td align="left" valign="top">Linolenic acid</td>
<td align="char" valign="top" char=".">29.70</td>
</tr>
<tr>
<td align="left" valign="top">C20:0</td>
<td align="left" valign="top">Elcosadienoic acid</td>
<td align="char" valign="top" char=".">0.68</td>
</tr>
<tr>
<td align="left" valign="top">C20:0</td>
<td align="left" valign="top">Elcosatrienoic acid</td>
<td align="char" valign="top" char=".">0.41</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>SFA, Saturated fatty acids; MUFA, Monounsaturated fatty; PUFA, Polyunsaturated fatty acids.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec6">
<title>Exercise training protocol</title>
<p>Before the interventions, all rats were familiarized with treadmill running for 1&#x2009;week (10&#x2009;min per day) at a speed of 8&#x2013;10&#x2009;m per min with a 0% incline. Afterward, HIIT was performed 5&#x2009;days per week for 8&#x2009;weeks on a treadmill at 6&#x2009;p.m. (lights off). The HIIT program involved 8 sets of 3&#x2009;min of high-intensity running at 85%&#x2013;90% of one&#x2019;s maximum speed, followed by 2&#x2009;min of active rest at 30%&#x2013;40% of one&#x2019;s maximum speed. The HIIT protocol comprised 5-min warm-up and cool-down intervals that were low-intensity (30%&#x2013;40% of maximum speed) before and after each session. To determine the maximal speed at the time of maximum oxygen consumption (VO2 max), rats ran 5&#x2009;m on a treadmill at a speed of 6&#x2009;m/min with a zero-degree gradient for 5&#x2009;min (warm-up), and then the treadmill speed increased to 3&#x2009;m/min every 3&#x2009;min until the animals reached the point of extinction and could no longer continue. The incapacity of the rats to continue the workout program with increasing speed and collision three times in 1&#x2009;min to the end of the treadmill was the criterion for reaching VO2 max, hence VO2 max was assessed using speed. Every 2&#x2009;weeks, the animals were assessed, and the training intensity was determined based on the new test values.</p>
</sec>
<sec id="sec7">
<title>Experimental procedures</title>
<p>After fasting for 12&#x2013;14&#x2009;h, and 48&#x2009;h after the previous training session, all rats were sedated with a painless intraperitoneal injection of ketamine (90&#x2009;mg/kg) and zailazin (10&#x2009;mg/kg). Blood was collected from the tail vein; plasma was separated <italic>via</italic> centrifuging at 3,500&#x2009;rpm for 5&#x2009;min. After blood sampling, the animals were sacrificed and the livers were removed. The liver tissue samples and serum samples were flash-frozen and stored at &#x2212;70&#x00B0;C, and the remaining livers were used for histopathological study and were homogenized in appropriate buffers for analysis of biochemical parameters like inflammatory and oxidative stress indices of the liver. Based on the aim of present study, markers of liver function, inflammation and oxidative stress were the main outcomes and glycemia markers and hepatic histopathology were secondary outcomes.</p>
</sec>
<sec id="sec8">
<title>Measurement of hepatic TNF-&#x03B1;</title>
<p>TNF-&#x03B1; levels were measured using an ELISA kit (catalog no. DY510-05, R&#x0026;D System) after liver tissue aliquots were homogenized in accordance with the manufacturer&#x2019;s instructions. All TNF-&#x03B1; analysis were carried out in duplicate serial dilutions.</p>
</sec>
<sec id="sec9">
<title>Measurement of hepatic MDA and TAC</title>
<p>The presence of malondialdehyde (MDA), a sign of lipid peroxidation, was measured. In a nutshell, livers were treated as previously reported after being homogenized in a solution of 1.15% KCl (<xref ref-type="bibr" rid="ref26">26</xref>). By comparing the OD550 of the reference solutions of 1,1,3,3-tetramethoxypropan 99% malondialdehyde bis (dymethyl acetal) 99% (Sigma), the sample absorbance was determined by spectrophotometry, and MDA values were derived (<xref ref-type="bibr" rid="ref41">41</xref>). A decrease in the production of thiobarbituric acid reactive compounds served as the basis for measuring the hepatic total antioxidant capacity (TAC) (<xref ref-type="bibr" rid="ref42">42</xref>). A commercially available colorimetric kit (Bioquochem FRAP Assay Kit, KF-01-003, R&#x0026;D System) was used to measure the hepatic TAC levels in accordance with the manufacturer&#x2019;s recommendations. Results were adjusted for protein levels (<xref ref-type="bibr" rid="ref43">43</xref>).</p>
</sec>
<sec id="sec10">
<title>Measurement of hepatic TG</title>
<p>Hepatic triglyceride (TG) concentrations were measured using commercially available colorimetric kits (Triglyceride G-Test kit, Wako Pure Chemical Industries) according to manufacturer instructions.</p>
</sec>
<sec id="sec11">
<title>Hepatic PGC-1&#x03B1; and PPAR-&#x03B3;</title>
<p>Western Blotting methods were used to messure protein levels of hepatic PGC-1&#x03B1; and PPAR-&#x03B3;. Protein lysates were isolated from 500&#x2009;mg of liver tissue in lysis buffer (500&#x2009;&#x03BC;L Tris, PH&#x2009;=&#x2009;8, 150&#x2009;mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 0.1&#x2009;mM EDTA) supplemented with a complete protease inhibitor cocktail and centrifuged at 12,000<italic>g</italic> for 10&#x2009;min at 4&#x00B0;C. The Bradford method was used to determine the protein concentration in the supernatant (<xref ref-type="bibr" rid="ref44">44</xref>). Proteins were separated using SDS-polyacrylamide gel electrophoresis with 8%&#x2013;12% denatured ready gel (Bio-Rad, Hercules, CA, United States) and transferred to a PVDF membrane (Roche, West Sussex, United Kingdom). To prevent nonspecific bindings, the membrane was blocked for 1&#x2009;h in 5% BSA in tris-buffered saline and 0.1% Tween 20 (TBST). Blots were then incubated overnight at 4<sup>&#x00B0;</sup> C with the following primary antibodies: &#x03B2;-actin (sc-47,778, 1: 300), PPAR-&#x03B3; (ab20935), and PGC-1&#x03B1; (ab54481), all purchased from Cell Signaling Technology. The membrane was then washed three times and incubated for 1&#x2009;h at room temperature in 5% milk in TBST with the appropriate secondary antibody (m-IgG BP-HRP: sc-516,102, and mouse anti-rabbit IgG-HRP: sc-2,357) (<xref ref-type="bibr" rid="ref44">44</xref>). Protein bands were visualized using an enhanced chemiluminescence (ECL) reagent and quantified using densitometry analysis with Image J software.</p>
</sec>
<sec id="sec12">
<title>Liver histopathological study</title>
<p>After being cleaned with normal saline, liver tissues were fixed in 10% buffered formalin for 48&#x2009;h. For the purpose of the histological evaluation, samples were embedded in paraffin, divided into 5-lm pieces, stained with hematoxylin and eosin (H and E), and examined under a light microscope. Scores were made in 10 fields of each H and E-stained slide, which were then examined under a light microscope to determine the liver&#x2019;s histological, hydropic degeneration, microvesicular and macrovesicular vacuoles, sinusoidal congestion, and cell necrosis findings (<xref ref-type="bibr" rid="ref40">40</xref>). Scores for the histopathological results were none (&#x2212;), mild (+), moderate (++), and severe damage (+++) (<xref ref-type="bibr" rid="ref45">45</xref>, <xref ref-type="bibr" rid="ref46">46</xref>).</p>
</sec>
<sec id="sec13">
<title>Measurement of fasting blood glucose, insulin, HOMA-IR</title>
<p>Fasting blood glucose was measured by using commercially available colorimetric diagnostic kits (Pars Azmoon kit, Iran) according to the instructions. The level of insulin was determined using the rat Insulin ELISA Kit (ALPCO, Catalog no: 80-INSRTH-E01). HOMA-IR was employed to assess the IR <italic>via</italic> the following formula (<xref ref-type="bibr" rid="ref47">47</xref>):</p>
<disp-formula id="E1"><mml:math id="M1"><mml:mi mathvariant="normal">HOMA</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">R</mml:mi><mml:mo>=</mml:mo><mml:mfenced open="[" close="]"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">fasting insulin</mml:mi><mml:mspace width="thickmathspace"/><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">mU</mml:mi><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>&#x00D7;</mml:mo><mml:mi mathvariant="normal">fasting blood glucose</mml:mi><mml:mspace width="thickmathspace"/><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">mg</mml:mi><mml:mo stretchy="true">/</mml:mo><mml:mi mathvariant="normal">dL</mml:mi></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo stretchy="true">/</mml:mo><mml:mn>405</mml:mn></mml:math></disp-formula>
</sec>
<sec id="sec14">
<title>Statistical analysis</title>
<p>The Shapiro&#x2013;Wilk test was used to assess the distribution&#x2019;s normality. The variances were then shown to be homogenous by a Leven test. The mean differences between the groups were examined using a one-way analysis of variance (ANOVA). Using Tukey&#x2019;s Test, differences between two groups were measured. Means and SEM were used to express the data. Statistical significance was defined as a value of <italic>p</italic> &#x003C;&#x2009;0.05. Pearson correlation coefficients were used to ascertain the relationship between the variables. The statistical software SPSS was used for all calculations (Version 20.00).</p>
</sec>
</sec>
<sec id="sec15" sec-type="results">
<title>Results</title>
<sec id="sec16">
<title>Hepatic TNF-&#x03B1;</title>
<p>Hepatic TNF-&#x03B1; was significantly (<italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig2" ref-type="fig">Figure 2A</xref>) increased in the DC group compared to NC. In contrast, TNF-&#x03B1; decreased in all three intervention groups as compared to DC, an effect that was greater in D&#x2009;+&#x2009;CSO and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT as compared to D&#x2009;+&#x2009;HIIT alone.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>The effect of D, D&#x2009;+&#x2009;CSO, D&#x2009;+&#x2009;HIIT, and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT on hepatic <bold>(A)</bold> TNF-&#x03B1;, <bold>(B)</bold> MDA, <bold>(C)</bold> TAC, and <bold>(D)</bold> TG. One-way ANOVA followed by Tukey post-test was used. Data are represented as means&#x2009;&#x00B1;&#x2009;SEM and significant differences between groups are indicated by &#x002A;<italic>p</italic> &#x003C;&#x2009;0.05. NC, Normal control; DC, Diabetic control; D&#x2009;+&#x2009;CSO, Diabetic&#x2009;+&#x2009;camelina sativa oil; D&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;HIIT; D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT.</p>
</caption>
<graphic xlink:href="fnut-10-1102862-g002.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>Hepatic MDA and TAC</title>
<p>Hepatic MDA increased in the DC group compared to NC (<italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig2" ref-type="fig">Figure 2B</xref>). Hepatic MDA decreased in all three intervention groups compared to DC (<italic>p</italic> &#x003C;&#x2009;0.001). These decreases were greater with D&#x2009;+&#x2009;CSO and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT compared to D&#x2009;+&#x2009;HIIT. In addition, D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT significantly decreased hepatic MDA compared to D&#x2009;+&#x2009;CSO alone. Hepatic TAC decreased in the DC group compared to NC; however, it did not change significantly (<italic>p</italic> &#x003E;&#x2009;0.05, <xref rid="fig2" ref-type="fig">Figure 2C</xref>) with the three interventions.</p>
</sec>
<sec id="sec18">
<title>Hepatic TG</title>
<p>Hepatic TG increased in the DC group compared to NC (<italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig2" ref-type="fig">Figure 2D</xref>), and decreased significantly in D&#x2009;+&#x2009;HIIT and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT compared to DC. In addition, Hepatic TG decreased in D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT compared to D&#x2009;+&#x2009;CSO alone. Changes in D&#x2009;+&#x2009;CSO alone were not statistically significant as compared with DC (<italic>p</italic> &#x003E;&#x2009;0.05).</p>
</sec>
<sec id="sec19">
<title>Hepatic PGC-1&#x03B1; and PPAR-&#x03B3;</title>
<p>Hepatic PGC-1&#x03B1; and PPAR-&#x03B3; decreased in the DC group compared to NC. In contrast, both PGC-1&#x03B1; and PPAR-&#x03B3; increased in all three intervention groups as compared to DC. For PGC-1&#x03B1;, D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT significantly increased hepatic PGC-1&#x03B1; as compared to D&#x2009;+&#x2009;HIIT alone (<italic>p</italic> &#x003C;&#x2009;0.001) and D&#x2009;+&#x2009;CSO alone (<italic>p</italic> &#x003C;&#x2009;0.001). In addition, D&#x2009;+&#x2009;CSO significantly increased hepatic PGC-1&#x03B1; as compared to D&#x2009;+&#x2009;HIIT alone (<italic>p</italic> &#x003C;&#x2009;0.001). For PPAR-&#x03B3;, D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT and D&#x2009;+&#x2009;CSO alone significantly increased hepatic PPAR-&#x03B3; as compared to D&#x2009;+&#x2009;HIIT alone (<italic>p</italic> &#x003C;&#x2009;0.001 and <italic>p</italic> &#x003C;&#x2009;0.05, respectively). But there was not a significant difference between D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT and D&#x2009;+&#x2009;CSO alone (<italic>p</italic> &#x003E;&#x2009;0.05; <xref rid="fig3" ref-type="fig">Figure 3</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Western bloting analysis of protein expression of &#x03B2;-actin, PGC-1&#x03B1;, and PPARy. The effect of D, D&#x2009;+&#x2009;CSO, D&#x2009;+&#x2009;HIIT, and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT on PGC-1&#x03B1;, and PPARy. NC, Normal control; DC, Diabetic control; D&#x2009;+&#x2009;CSO, Diabetic&#x2009;+&#x2009;camelina sativa oil; D&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;HIIT; D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT.</p>
</caption>
<graphic xlink:href="fnut-10-1102862-g003.tif"/>
</fig>
</sec>
<sec id="sec20">
<title>Hepatic histopathology</title>
<p>Hepatic histopathology markers including hydropic degeneration, micro-vesicular vacuoles, macro-vesicular vacuoles, and sinusoidal congestion were increased in the DC group compared to NC, whereas these markers were decreased in all three intervention groups compared to DC (<xref rid="tab2" ref-type="table">Table 2</xref>). These decreases were more significant in D + CSO + HIIT as compared with D + CSO and D+ HIIT alone (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>The effect of DC, D&#x2009;+&#x2009;CSO, D&#x2009;+&#x2009;HIIT, and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT on hepatic histopathology, 400 <inline-formula><mml:math id="M2"><mml:mo>&#x00D7;</mml:mo></mml:math></inline-formula> magnification, DC, Diabetic control; D&#x2009;+&#x2009;CSO, Diabetic&#x2009;+&#x2009;camelina sativa oil; D&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;HIIT; D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT.</p>
</caption>
<graphic xlink:href="fnut-10-1102862-g004.tif"/>
</fig>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The effect of camelina sativa oil and HIIT on changes in liver histopathology of male type 2 diabetic rats.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Groups</th>
<th align="center" valign="top">Hydropic degeneration</th>
<th align="center" valign="top">Microvesicular vacuoles</th>
<th align="center" valign="top">Macrovesicular vacuoles</th>
<th align="center" valign="top">Sinusoidal congestion</th>
<th align="center" valign="top">Cell necrosis</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">NC</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top">DC</td>
<td align="center" valign="top">3+</td>
<td align="center" valign="top">3+</td>
<td align="center" valign="top">3+</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">3+</td>
</tr>
<tr>
<td align="left" valign="top">D&#x2009;+&#x2009;HIIT</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">3+</td>
<td align="center" valign="top">3+</td>
<td align="center" valign="top">2+</td>
</tr>
<tr>
<td align="left" valign="top">D&#x2009;+&#x2009;CSO</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">2+</td>
<td align="center" valign="top">1+</td>
</tr>
<tr>
<td align="left" valign="top">D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">1+</td>
<td align="center" valign="top">1+</td>
<td align="center" valign="top">1+</td>
<td align="center" valign="top">0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>NC, normal control; DC, diabetic control; D&#x2009;+&#x2009;CSO, diabetic + camelina sativa oil; D&#x2009;+&#x2009;HIIT, Diabetic + HIIT; D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec21">
<title>Glycaemia markers</title>
<p>Fasting plasma glucose and HOMA-IR were significantly (<italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig5" ref-type="fig">Figure 5A</xref>; <italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig5" ref-type="fig">Figure 5C</xref>) increased in diabetic rats compared to NC. In contrast, fasting plasma glucose in all three interventions (D + CSO, D + HIIT, and D + CSO + HIIT) and HOMA-IR in D + CSO and D + CSO + HIIT were decreased compared to DC. In addition, D + CSO+ HIIT significantly (<italic>p</italic> &#x003C;&#x2009;0.001) decreased fasting glucose and HOMA-IR compared to D&#x2009;+&#x2009;HIIT alone (<italic>p</italic> &#x003C;&#x2009;0.001). Also, D+CSO significantly decreased fasting plasma glucose and HOMA-IR compared to D+HIIT (<italic>p</italic> &#x003C;&#x2009;0.001). However, fasting plasma insulin changes were not significantly (<italic>p</italic> &#x003E;&#x2009;0.05, <xref rid="fig5" ref-type="fig">Figure 5B</xref>) different between groups.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The effect of D, D&#x2009;+&#x2009;CSO, D&#x2009;+&#x2009;HIIT, and D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT on glycemia markers including <bold>(A)</bold> glucose, <bold>(B)</bold> insulin, and <bold>(C)</bold> HOMA-IR. One-way ANOVA followed by Tukey post-test was used. Data are represented as means&#x2009;&#x00B1;&#x2009;SEM and significant differences between groups are indicated by &#x002A;<italic>p</italic> &#x003C;&#x2009;0.05. NC, Normal control; DC, Diabetic control; D&#x2009;+&#x2009;CSO, Diabetic&#x2009;+&#x2009;camelina sativa oil; D&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;HIIT; D&#x2009;+&#x2009;c&#x2009;+&#x2009;HIIT, Diabetic&#x2009;+&#x2009;camelina sativa oil&#x2009;+&#x2009;HIIT.</p>
</caption>
<graphic xlink:href="fnut-10-1102862-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="sec22" sec-type="discussions">
<title>Discussion</title>
<p>There has been some previous research examining the independent effects of CSO and HIIT on glycemic control (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref48">48</xref>, <xref ref-type="bibr" rid="ref49">49</xref>); however, there is no previously published study on the combined effects of CSO and HIIT, in particular in a T2DM model or in patients with T2DM. Therefore, in the present study, the combined effects of CSO and HIIT on glycemic indices, inflammatory and oxidative stress markers in hepatic cells, hepatic triglyceride content, and liver histopathological findings were investigated in male T2DM rats. According to our findings, there were improving synergistic effects of CSO and HIIT for 8 weeks on glucose, HOMA-IR, hepatic MDA, TNF-&#x03B1;, TG, PPAR-&#x03B3;, PGC-1&#x03B1; and histopathology markers; however, insulin and TAC did not change significantly in three intervention groups.</p>
<p>Our results suggest that CSO, as a rich source of omega-3 fatty acids exerted positive effects on glycemic and insulin resistance markers, in agreement with previous research in patients with NAFLD (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>) and impaired glucose metabolism (<xref ref-type="bibr" rid="ref48">48</xref>). The proposed anti-hyperglycemic mechanisms of action by which CSO may influence insulin resistance are mostly related to its omega-3 fatty acids contents. Omega-3 fatty acids are thought to improve insulin resistance by modulating mitochondrial bioenergetics and endoplasmic reticulum stress, and through upregulation of PPAR-&#x03B3;, one of the main regulators of glucose homeostasis (<xref ref-type="bibr" rid="ref50">50</xref>, <xref ref-type="bibr" rid="ref51">51</xref>). Moreover, HIIT improves insulin resistance by increasing mitochondrial biogenesis, GLUT-4 translocation, and PGC-1&#x03B1; (<xref ref-type="bibr" rid="ref52">52</xref>). Therefore, the synergistic effects of CSO and HIIT on glycemic parameters might be related to their shared effects on mitochondrial bioenergetics, PPAR-&#x03B3; activity, and GLUT-4 translocation. Our findings showed that CSO increased PPAR-&#x03B3; protein expression. In line with our findings, Taranu et al. and Tejera et al., using <italic>in-vivo</italic> models, reported that &#x03C9;-3 PUFA rich CSO increased PPAR-&#x03B3; expression (<xref ref-type="bibr" rid="ref53">53</xref>, <xref ref-type="bibr" rid="ref54">54</xref>). Moreover, &#x03C9;-3 PUFAs have been recognized as the natural agonists of PPAR-&#x03B3; (<xref ref-type="bibr" rid="ref55">55</xref>). The current study, for the first time, evaluated the effects of CSO plus HIIT on PPAR-&#x03B3; protein expression in an animal model. However, our study did not show a beneficial effect for HIIT on PPAR-&#x03B3;. Similar result were obtained from another <italic>in-vivo</italic> investigation (<xref ref-type="bibr" rid="ref56">56</xref>). However, another long-term study (12&#x2009;weeks) in rats reported that HIIT led to a significant increase in PPAR-&#x03B3; expression following a high-fat diet (<xref ref-type="bibr" rid="ref57">57</xref>). Therefore, additional studies with longer durations may show a synergistic effect for CSO and HIIT on PPAR-&#x03B3; expression. This synergistic effect for CSO and HIIT on PGC-1&#x03B1; protein expression was shown for the first time in our study. Additional studies are needed to elucidate other anti-hyperglycemic machanisms of action of HIIT plus CSO, including their possible synergistic effects on GLUT4 translocation and mitochondrial bioenergetics.</p>
<p>Only a few previous studies have investigated the anti-oxidant and anti-inflammatory properties of CSO. In agreement with the current study results, Kavyani et al. showed that co-supplementation of CSO and prebiotics for 12&#x2009;weeks led to significant decreases in MDA and hs-CRP, and increases in TAC among patients with NAFLD (<xref ref-type="bibr" rid="ref6">6</xref>). Musazadeh et al. reported similar results with CSO plus a calorie-restricted diet for 12&#x2009;weeks in patients with NAFLD (<xref ref-type="bibr" rid="ref5">5</xref>). An <italic>in-vivo</italic> study showed that CSO supplementation led to significant increases in the activity of anti-oxidant enzymes along with significant decreases in MDA levels (<xref ref-type="bibr" rid="ref58">58</xref>). Regarding TAC, our study results conflict with this previous evidence, and the differences between the current TAC results and previous results may be related to the duration of supplementation (12&#x2009;weeks vs. 8&#x2009;weeks). Kavyani et al. demonstrated anti-inflammatory properties of omega-3 fatty acids (<xref ref-type="bibr" rid="ref15">15</xref>). It is well established that oxidative stress plays a key role in the pathophysiology of insulin resistance and T2DM (<xref ref-type="bibr" rid="ref59">59</xref>, <xref ref-type="bibr" rid="ref60">60</xref>), and there is an increasing body of evidence from animal studies confirming oxidative stress-induced insulin resistance and the improvement in insulin signal transduction and glucose homeostasis through use of antioxidants (<xref ref-type="bibr" rid="ref61">61</xref>&#x2013;<xref ref-type="bibr" rid="ref63">63</xref>).</p>
<p>Omega-3 fatty acids can modulate immune system function (<xref ref-type="bibr" rid="ref64">64</xref>) and the production of pro-inflammatory cytokines (<xref ref-type="bibr" rid="ref65">65</xref>). Moreover, omega-3 fatty acids are natural PPAR-&#x03B3; agonists and can inhibit Nuclear Factor-Kappa-B (NF-&#x0138;B) activity, the main modulator of inflammatory cascades (<xref ref-type="bibr" rid="ref66">66</xref>). The anti-oxidant effects of omega-3 fatty acids are mainly related to changes in cellular membrane structures leading to decreases in lipid peroxidation (<xref ref-type="bibr" rid="ref13">13</xref>). Moreover, other compounds in CSO such as phytosterols, carotenoids, and tocopherols contribute to its anti-oxidant effects (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>It&#x2019;s been hypothesized that activities that increase oxygen consumption can increase free radicals and oxidative stress (<xref ref-type="bibr" rid="ref67">67</xref>). Acutely, HIIT induces oxidative stress and lipid peroxidation by increasing NADPH oxidase, xanthine oxidase, phospholipase A2 activity, mitochondrial cytochrome c, and catecholamine oxidation (<xref ref-type="bibr" rid="ref68">68</xref>, <xref ref-type="bibr" rid="ref69">69</xref>). However, with chronic exercise training, there are adaptive mechanisms that contribute to the reduction of oxidative stress, including the upregulation of redox signaling cascades and endogenous antioxidant enzymes, muscle hypertrophy, glucose uptake by skeletal muscle, and mitochondrial biogenesis (<xref ref-type="bibr" rid="ref70">70</xref>). However, co-supplementation with an antioxidant-rich source such as CSO is necessary to accelerate the balance of oxidative stress induced by HIIT.</p>
<p>Beneficial synergistic effects for D&#x2009;+&#x2009;CSO&#x2009;+&#x2009;HIIT on hepatic TG, hepatic histopathology, and expression of PGC-1&#x03B1; were demonstrated in the current study. Previous studies have suggested that HIIT performed for 12&#x2009;weeks significantly reduces intrahepatic lipid levels (<xref ref-type="bibr" rid="ref71">71</xref>, <xref ref-type="bibr" rid="ref72">72</xref>). However, Winn et al. showed that the reduction of intrahepatic lipid levels did not significantly differ between different exercise intensities after 4&#x2009;weeks (<xref ref-type="bibr" rid="ref73">73</xref>). Similarly to our study, Kamal et al. investigated the effects of an 8-week HIIT program and found that HIIT was effective in decreasing intrahepatic lipid levels. However, most study participants received metformin, which can also have beneficial effects on hepatic fat levels (<xref ref-type="bibr" rid="ref74">74</xref>). Also in agreement with the current results, hepatic histopathology examination in an <italic>in-vivo</italic> study revealed that 8&#x2009;weeks of HIIT improved liver function (<xref ref-type="bibr" rid="ref75">75</xref>). The current results showed that HIIT for 8&#x2009;weeks can be beneficial in improving hepatic triglyceride levels.</p>
<p>In terms of hepatoprotective effects of CSO, Musazadeh et al. in a clinical trial study on NAFLD patients showed that CSO supplementation led to a significant decrease in alanine aminotransferase, an enzyme indicating a poor liver function in high levels. However, other liver enzymes did not significantly differ between CSO and placebo groups (<xref ref-type="bibr" rid="ref21">21</xref>). A previous narrative review reported that improvement in hepatic steatosis and liver function following HIIT was associated with improved liver mitochondrial function, increased hepatic PPAR-&#x03B1;, and PPAR-&#x03B3; content, improved insulin sensitivity, and suppression of hepatic <italic>de novo</italic> lipogenesis (<xref ref-type="bibr" rid="ref76">76</xref>). The cellular mechanisms responsible for the positive effects of CSO on liver function have not been fully elucidated. However, anti-inflammatory, antioxidant, and anti-hyperlipidemia effects, and regulation of glucose homeostasis have been suggested. Also, the effects of omega-3 fatty acids on liver function have been investigated in previous studies (<xref ref-type="bibr" rid="ref77">77</xref>, <xref ref-type="bibr" rid="ref78">78</xref>). Other plant-based omega-3 fatty acid sources such as flax seed (<xref ref-type="bibr" rid="ref79">79</xref>), walnut (<xref ref-type="bibr" rid="ref80">80</xref>), or chia (<xref ref-type="bibr" rid="ref81">81</xref>) exerted hepatoprotective effects.</p>
<p>The current study is the first to investigate the synergistic effects of CSO and HIIT on glycemic, inflammatory, oxidative stress, and total antioxidant capacity biomarkers and liver function in an animal model of T2DM.</p>
<p>Some limitations should be considered when interpreting results. First, the overall treatment duration was short as compared to some similar studies. However, our results were in agreement with most studies of longer durations. Second, other biomarkers of inflammation, oxidative stress, and liver function were not included. For example, various interleukins, hs-CRP, antioxidant enzymes, aspartate aminotransferase (AST), and alanine transaminase (ALT) were not studied. Results may have differed if we had used other or additional biomarkers, in particular, antioxidant capacity should be further elucidated. Of course, a rat model of T2DM does not necessarily generalize to human participants with T2DM. Therefore, further studies in both animal and human models should be conducted to clarify all aspects of the effects of CSO and HIIT in type 2 diabetes. However, the strengths of our study should also be mentioned. Our study was the first to evaluate the synergistic effects of CSO plus HIIT on liver function, and metabolic outcomes, as well as glycemic markers in an animal model of T2DM. In addition, Western-blotting as an accurate method was performed to reach a more accurate conclusion of the antihyperglycemic mechanisms of CSO plus HIIT. Whereas, most similar studies assessed gene expression with real-time PCR methods. The current study also investigated various biomarkers to obtain a more comprehensive picture of the beneficial effects of CSO plus HIIT on T2DM to pave the way for future clinical trials.</p>
</sec>
<sec id="sec23" sec-type="conclusions">
<title>Conclusion</title>
<p>The current study indicated that CSO and HIIT, independently and combined, exerted beneficial effects on fasting blood glucose, HOMA-IR, hepatic TNF-&#x03B1;, MDA, TG, PPAR-&#x03B3;, PGC-1&#x03B1;, and histopathology markers. Only hepatic TAC and fasting plasma insulin remained unaffected in all the three interventions groups. However, combination of CSO and HIIT had the largest effect on liver function and metabolic outcomes other than CSO and HIIT alone.</p>
</sec>
<sec id="sec24" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="sec25">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by the Veterinary Ethics Committee of Tabriz University of Medical Sciences (approval no.: IR.TBZMED.AEC.1401.040). Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="sec26">
<title>Author contributions</title>
<p>ZK: drafting of the manuscript, acquisition of data, and approval of the article. PD: contributions to concept/design, data analysis/interpretation, critical revision of the manuscript, and approval of the article. MosK: contributions to implementation of the study, critical revision of the manuscript, and approval of the article. MouK: contributions to data analysis/interpretation, critical revision of the manuscript, and approval of the article. SR: contributions to design of the study, critical revision of the manuscript, and approval of the article. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec27" sec-type="funding-information">
<title>Funding</title>
<p>This study was funded by the Vice-chancellor for Research and Student Research Committee of Tabriz University of Medical Sciences, Tabriz, Iran (grant number: 69899).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>The study was accomplished in the Biochemistry Department of Tabriz University of Medical Sciences and the authors sincerely thank all cooperators to carry out this project at the university.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farhangi</surname> <given-names>MA</given-names></name> <name><surname>Dehghan</surname> <given-names>P</given-names></name> <name><surname>Namazi</surname> <given-names>N</given-names></name></person-group>. <article-title>Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial</article-title>. <source>Eur J Nutr</source>. (<year>2020</year>) <volume>59</volume>:<fpage>3009</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-019-02140-z</pub-id>, PMID: <pub-id pub-id-type="pmid">31728681</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>G-J</given-names></name> <name><surname>Shi</surname> <given-names>G-R</given-names></name> <name><surname>Zhou</surname> <given-names>J-Y</given-names></name> <name><surname>Zhang</surname> <given-names>W-J</given-names></name> <name><surname>Gao</surname> <given-names>C-Y</given-names></name> <name><surname>Jiang</surname> <given-names>Y-P</given-names></name> <etal/></person-group>. <article-title>Involvement of growth factors in diabetes mellitus and its complications: a general review</article-title>. <source>Biomed Pharmacother</source>. (<year>2018</year>) <volume>101</volume>:<fpage>510</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2018.02.105</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dehdashtian</surname> <given-names>E</given-names></name> <name><surname>Mehrzadi</surname> <given-names>S</given-names></name> <name><surname>Yousefi</surname> <given-names>B</given-names></name> <name><surname>Hosseinzadeh</surname> <given-names>A</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name> <name><surname>Safa</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress</article-title>. <source>Life Sci</source>. (<year>2018</year>) <volume>193</volume>:<fpage>20</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2017.12.001</pub-id>, PMID: <pub-id pub-id-type="pmid">29203148</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>G-J</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Cao</surname> <given-names>Q-H</given-names></name> <name><surname>Wu</surname> <given-names>H-X</given-names></name> <name><surname>Tang</surname> <given-names>X-Y</given-names></name> <name><surname>Gao</surname> <given-names>X-H</given-names></name> <etal/></person-group>. <article-title>In vitro and in vivo evidence that quercetin protects against diabetes and its complications: a systematic review of the literature</article-title>. <source>Biomed Pharmacother</source>. (<year>2019</year>) <volume>109</volume>:<fpage>1085</fpage>&#x2013;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2018.10.130</pub-id>, PMID: <pub-id pub-id-type="pmid">30551359</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Musazadeh</surname> <given-names>V</given-names></name> <name><surname>Dehghan</surname> <given-names>P</given-names></name> <name><surname>Saleh-Ghadimi</surname> <given-names>S</given-names></name> <name><surname>Abbasalizad</surname> <given-names>FM</given-names></name></person-group>. <article-title>Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: a randomised placebo-controlled clinical trial</article-title>. <source>Int J Clin Pract</source>. (<year>2021</year>) <volume>75</volume>:<fpage>e14744</fpage>. doi: <pub-id pub-id-type="doi">10.1111/ijcp.14744</pub-id>, PMID: <pub-id pub-id-type="pmid">34423525</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavyani</surname> <given-names>M</given-names></name> <name><surname>Saleh-Ghadimi</surname> <given-names>S</given-names></name> <name><surname>Dehghan</surname> <given-names>P</given-names></name> <name><surname>Khoshbaten</surname> <given-names>M</given-names></name></person-group>. <article-title>Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial</article-title>. <source>Food Funct</source>. (<year>2021</year>) <volume>12</volume>:<fpage>8594</fpage>&#x2013;<lpage>604</lpage>. doi: <pub-id pub-id-type="doi">10.1039/D1FO00448D</pub-id>, PMID: <pub-id pub-id-type="pmid">34338703</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tutunchi</surname> <given-names>H</given-names></name> <name><surname>Ostadrahimi</surname> <given-names>A</given-names></name> <name><surname>Saghafi-Asl</surname> <given-names>M</given-names></name> <name><surname>Hosseinzadeh-Attar</surname> <given-names>M-J</given-names></name> <name><surname>Shakeri</surname> <given-names>A</given-names></name> <name><surname>Asghari-Jafarabadi</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: effects on metabolic parameters, anthropometric indices, and expression of PPAR-&#x03B1;, UCP1, and UCP2 genes</article-title>. <source>Pharmacol Res</source>. (<year>2020</year>) <volume>156</volume>:<fpage>104770</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2020.104770</pub-id>, PMID: <pub-id pub-id-type="pmid">32217148</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>L</given-names></name> <name><surname>Sha</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>K</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>T</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus <italic>via</italic> anti-inflammation and modulating gut microbiota in rats</article-title>. <source>Lipids Health Dis</source>. (<year>2020</year>) <volume>19</volume>:<fpage>20</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-019-1167-4</pub-id>, PMID: <pub-id pub-id-type="pmid">32028957</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akinkuolie</surname> <given-names>AO</given-names></name> <name><surname>Ngwa</surname> <given-names>JS</given-names></name> <name><surname>Meigs</surname> <given-names>JB</given-names></name> <name><surname>Djouss&#x00E9;</surname> <given-names>L</given-names></name></person-group>. <article-title>Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials</article-title>. <source>Clin Nutr</source>. (<year>2011</year>) <volume>30</volume>:<fpage>702</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2011.08.013</pub-id>, PMID: <pub-id pub-id-type="pmid">21959352</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thota</surname> <given-names>RN</given-names></name> <name><surname>Acharya</surname> <given-names>SH</given-names></name> <name><surname>Garg</surname> <given-names>ML</given-names></name></person-group>. <article-title>Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial</article-title>. <source>Lipids Health Dis</source>. (<year>2019</year>) <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-019-0967-x</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobyliak</surname> <given-names>N</given-names></name> <name><surname>Falalyeyeva</surname> <given-names>T</given-names></name> <name><surname>Mykhalchyshyn</surname> <given-names>G</given-names></name> <name><surname>Molochek</surname> <given-names>N</given-names></name> <name><surname>Savchuk</surname> <given-names>O</given-names></name> <name><surname>Kyriienko</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: a randomised controlled trial</article-title>. <source>Obesity Med</source>. (<year>2020</year>) <volume>19</volume>:<fpage>100248</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.obmed.2020.100248</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soleimani</surname> <given-names>A</given-names></name> <name><surname>Taghizadeh</surname> <given-names>M</given-names></name> <name><surname>Bahmani</surname> <given-names>F</given-names></name> <name><surname>Badroj</surname> <given-names>N</given-names></name> <name><surname>Asemi</surname> <given-names>Z</given-names></name></person-group>. <article-title>Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Clin Nutr</source>. (<year>2017</year>) <volume>36</volume>:<fpage>79</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2015.11.003</pub-id>, PMID: <pub-id pub-id-type="pmid">26611718</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heshmati</surname> <given-names>J</given-names></name> <name><surname>Morvaridzadeh</surname> <given-names>M</given-names></name> <name><surname>Maroufizadeh</surname> <given-names>S</given-names></name> <name><surname>Akbari</surname> <given-names>A</given-names></name> <name><surname>Yavari</surname> <given-names>M</given-names></name> <name><surname>Amirinejad</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Omega-3 fatty acids supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials</article-title>. <source>Pharmacol Res</source>. (<year>2019</year>) <volume>149</volume>:<fpage>104462</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2019.104462</pub-id>, PMID: <pub-id pub-id-type="pmid">31563611</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellulu</surname> <given-names>MS</given-names></name> <name><surname>Khaza'ai</surname> <given-names>H</given-names></name> <name><surname>Patimah</surname> <given-names>I</given-names></name> <name><surname>Rahmat</surname> <given-names>A</given-names></name> <name><surname>Abed</surname> <given-names>Y</given-names></name></person-group>. <article-title>Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial</article-title>. <source>Food Nutr Res</source>. (<year>2016</year>) <volume>60</volume>:<fpage>29268</fpage>. doi: <pub-id pub-id-type="doi">10.3402/fnr.v60.29268</pub-id>, PMID: <pub-id pub-id-type="pmid">26829184</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavyani</surname> <given-names>Z</given-names></name> <name><surname>Musazadeh</surname> <given-names>V</given-names></name> <name><surname>Fathi</surname> <given-names>S</given-names></name> <name><surname>Hossein Faghfouri</surname> <given-names>A</given-names></name> <name><surname>Dehghan</surname> <given-names>P</given-names></name> <name><surname>Sarmadi</surname> <given-names>B</given-names></name></person-group>. <article-title>Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis</article-title>. <source>Int Immunopharmacol</source>. (<year>2022</year>) <volume>111</volume>:<fpage>109104</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2022.109104</pub-id>, PMID: <pub-id pub-id-type="pmid">35914448</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>G</given-names></name> <name><surname>Qiong</surname> <given-names>Z</given-names></name> <name><surname>Yong-Hua</surname> <given-names>W</given-names></name></person-group>. <article-title>Health effects of Omega-3 polyunsaturated fatty acids in common diseases</article-title>. <source>Int Food Res J</source>. (<year>2021</year>) <volume>28</volume>:<fpage>1098</fpage>&#x2013;<lpage>108</lpage>. doi: <pub-id pub-id-type="doi">10.47836/ifrj.28.6.01</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alami</surname> <given-names>F</given-names></name> <name><surname>Alizadeh</surname> <given-names>M</given-names></name> <name><surname>Shateri</surname> <given-names>K</given-names></name></person-group>. <article-title>The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial</article-title>. <source>Scand J Gastroenterol</source>. (<year>2022</year>) <volume>57</volume>:<fpage>1238</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00365521.2022.2071109</pub-id>, PMID: <pub-id pub-id-type="pmid">35710164</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cernea</surname> <given-names>S</given-names></name> <name><surname>Cahn</surname> <given-names>A</given-names></name> <name><surname>Raz</surname> <given-names>I</given-names></name></person-group>. <article-title>Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes</article-title>. <source>Expert Rev Clin Pharmacol</source>. (<year>2017</year>) <volume>10</volume>:<fpage>535</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1080/17512433.2017.1300059</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saleh-Ghadimi</surname> <given-names>S</given-names></name> <name><surname>Alizadeh</surname> <given-names>M</given-names></name> <name><surname>Jafari-Vayghan</surname> <given-names>H</given-names></name> <name><surname>Darabi</surname> <given-names>M</given-names></name> <name><surname>Golmohammadi</surname> <given-names>A</given-names></name> <name><surname>Kheirouri</surname> <given-names>S</given-names></name></person-group>. <article-title>Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial</article-title>. <source>Genes Nutr</source>. (<year>2020</year>) <volume>15</volume>:<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12263-020-00665-1</pub-id>, PMID: <pub-id pub-id-type="pmid">32370762</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zubr</surname> <given-names>J</given-names></name> <name><surname>Matth&#x00E4;us</surname> <given-names>B</given-names></name></person-group>. <article-title>Effects of growth conditions on fatty acids and tocopherols in Camelina sativa oil</article-title>. <source>Ind Crop Prod</source>. (<year>2002</year>) <volume>15</volume>:<fpage>155</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0926-6690(01)00106-6</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Musazadeh</surname> <given-names>V</given-names></name> <name><surname>Dehghan</surname> <given-names>P</given-names></name> <name><surname>Khoshbaten</surname> <given-names>M</given-names></name></person-group>. <article-title>Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial</article-title>. <source>Eur J Gastroenterol Hepatol</source>. (<year>2022</year>) <volume>34</volume>:<fpage>537</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MEG.0000000000002297</pub-id>, PMID: <pub-id pub-id-type="pmid">35421019</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Detopoulou</surname> <given-names>P</given-names></name> <name><surname>Papamikos</surname> <given-names>V</given-names></name></person-group>. <article-title>Gastrointestinal bleeding after high intake of omega-3 fatty acids, cortisone and antibiotic therapy: a case study</article-title>. <source>Int J Sport Nutr Exerc Metab</source>. (<year>2014</year>) <volume>24</volume>:<fpage>253</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1123/ijsnem.2013-0204</pub-id>, PMID: <pub-id pub-id-type="pmid">24281788</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shawahna</surname> <given-names>R</given-names></name> <name><surname>Batta</surname> <given-names>A</given-names></name> <name><surname>Asa&#x2019;ad</surname> <given-names>M</given-names></name> <name><surname>Jomaah</surname> <given-names>M</given-names></name> <name><surname>Abdelhaq</surname> <given-names>I</given-names></name></person-group>. <article-title>Exercise as a complementary medicine intervention in type 2 diabetes mellitus: a systematic review with narrative and qualitative synthesis of evidence</article-title>. <source>Diabetes Metab Syndr Clin Res Rev</source>. (<year>2021</year>) <volume>15</volume>:<fpage>273</fpage>&#x2013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.dsx.2021.01.008</pub-id>, PMID: <pub-id pub-id-type="pmid">33482523</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname> <given-names>M</given-names></name> <name><surname>Cardillo</surname> <given-names>C</given-names></name></person-group>. <article-title>Exercise is medicine: key to cardiovascular disease and diabetes prevention</article-title>. <source>Cardiovasc Res</source>. (<year>2021</year>) <volume>117</volume>:<fpage>360</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cvr/cvaa226</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aldahr</surname> <given-names>MHS</given-names></name> <name><surname>Abd El-Kader</surname> <given-names>SM</given-names></name></person-group>. <article-title>Impact of exercise on renal function, oxidative stress, and systemic inflammation among patients with type 2 diabetic nephropathy</article-title>. <source>Afr Health Sci</source>. (<year>2022</year>) <volume>22</volume>:<fpage>286</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.4314/ahs.v22i3.30</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivero</surname> <given-names>A</given-names></name> <name><surname>Ruz</surname> <given-names>M</given-names></name> <name><surname>Rivera</surname> <given-names>M</given-names></name> <name><surname>Miranda</surname> <given-names>K</given-names></name> <name><surname>Sacrist&#x00E1;n</surname> <given-names>C</given-names></name> <name><surname>Espinosa</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Zinc supplementation and strength exercise in rats with type 2 diabetes: Akt and PTP1B phosphorylation in nonalcoholic fatty liver</article-title>. <source>Biol Trace Elem Res</source>. (<year>2021</year>) <volume>199</volume>:<fpage>2215</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12011-020-02324-3</pub-id>, PMID: <pub-id pub-id-type="pmid">32939643</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karlsen</surname> <given-names>T</given-names></name> <name><surname>Aamot</surname> <given-names>I-L</given-names></name> <name><surname>Haykowsky</surname> <given-names>M</given-names></name> <name><surname>Rognmo</surname> <given-names>&#x00D8;</given-names></name></person-group>. <article-title>High intensity interval training for maximizing health outcomes</article-title>. <source>Prog Cardiovasc Dis</source>. (<year>2017</year>) <volume>60</volume>:<fpage>67</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pcad.2017.03.006</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname> <given-names>Z</given-names></name> <name><surname>Root-Mccaig</surname> <given-names>J</given-names></name> <name><surname>Castellani</surname> <given-names>L</given-names></name> <name><surname>Kemp</surname> <given-names>BE</given-names></name> <name><surname>Steinberg</surname> <given-names>GR</given-names></name> <name><surname>Wright</surname> <given-names>DC</given-names></name></person-group>. <article-title>Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue</article-title>. <source>Obesity</source>. (<year>2014</year>) <volume>22</volume>:<fpage>730</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/oby.20605</pub-id>, PMID: <pub-id pub-id-type="pmid">23963743</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname> <given-names>M</given-names></name> <name><surname>Soto-Alarc&#x00F3;n</surname> <given-names>SA</given-names></name> <name><surname>Orellana</surname> <given-names>P</given-names></name> <name><surname>Espinosa</surname> <given-names>A</given-names></name> <name><surname>Campos</surname> <given-names>C</given-names></name> <name><surname>L&#x00F3;pez-Arana</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration</article-title>. <source>Dig Liver Dis</source>. (<year>2020</year>) <volume>52</volume>:<fpage>895</fpage>&#x2013;<lpage>904</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.dld.2020.04.019</pub-id>, PMID: <pub-id pub-id-type="pmid">32620521</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muralidaran</surname> <given-names>S</given-names></name> <name><surname>Roy</surname> <given-names>A</given-names></name></person-group>. <article-title>The role of PPAR agonists in diabetes mellitus</article-title>. <source>J Pharm Sci Res</source>. (<year>2016</year>) <volume>8</volume>:<fpage>864</fpage>.</citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname> <given-names>LN</given-names></name> <name><surname>Bomhof</surname> <given-names>MR</given-names></name> <name><surname>Capozzi</surname> <given-names>LC</given-names></name> <name><surname>Basaraba</surname> <given-names>SA</given-names></name> <name><surname>Wright</surname> <given-names>DC</given-names></name></person-group>. <article-title>Exercise and adrenaline increase PGC-1&#x03B1; mRNA expression in rat adipose tissue</article-title>. <source>J Physiol</source>. (<year>2009</year>) <volume>587</volume>:<fpage>1607</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2008.165464</pub-id>, PMID: <pub-id pub-id-type="pmid">19221126</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Son</surname> <given-names>SH</given-names></name> <name><surname>Lee</surname> <given-names>SM</given-names></name> <name><surname>Lee</surname> <given-names>MH</given-names></name> <name><surname>Son</surname> <given-names>YK</given-names></name> <name><surname>Kim</surname> <given-names>SE</given-names></name> <name><surname>An</surname> <given-names>WS</given-names></name></person-group>. <article-title>Omega-3 fatty acids upregulate SIRT1/3, activate PGC-1&#x03B1; <italic>via</italic> deacetylation, and induce Nrf 1 production in 5/6 nephrectomy rat model</article-title>. <source>Mar Drugs</source>. (<year>2021</year>) <volume>19</volume>:<fpage>182</fpage>. doi: <pub-id pub-id-type="doi">10.3390/md19040182</pub-id>, PMID: <pub-id pub-id-type="pmid">33810216</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tj&#x00F8;nna</surname> <given-names>AE</given-names></name> <name><surname>Lee</surname> <given-names>SJ</given-names></name> <name><surname>Rognmo</surname> <given-names>&#x00D8;</given-names></name> <name><surname>St&#x00F8;len</surname> <given-names>TO</given-names></name> <name><surname>Bye</surname> <given-names>A</given-names></name> <name><surname>Haram</surname> <given-names>PM</given-names></name> <etal/></person-group>. <article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title>. <source>Circulation</source>. (<year>2008</year>) <volume>118</volume>:<fpage>346</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.772822</pub-id>, PMID: <pub-id pub-id-type="pmid">18606913</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalafi</surname> <given-names>M</given-names></name> <name><surname>Mohebbi</surname> <given-names>H</given-names></name> <name><surname>Symonds</surname> <given-names>ME</given-names></name> <name><surname>Karimi</surname> <given-names>P</given-names></name> <name><surname>Akbari</surname> <given-names>A</given-names></name> <name><surname>Tabari</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>The impact of moderate-intensity continuous or high-intensity interval training on Adipogenesis and Browning of subcutaneous adipose tissue in obese male rats</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>925</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu12040925</pub-id>, PMID: <pub-id pub-id-type="pmid">32230849</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalafi</surname> <given-names>M</given-names></name> <name><surname>Mojtahedi</surname> <given-names>S</given-names></name> <name><surname>Ostovar</surname> <given-names>A</given-names></name> <name><surname>Rosenkranz</surname> <given-names>SK</given-names></name> <name><surname>Korivi</surname> <given-names>M</given-names></name></person-group>. <article-title>High-intensity interval exercise versus moderate-intensity continuous exercise on postprandial glucose and insulin responses: a systematic review and meta-analysis</article-title>. <source>Obes Rev</source>. (<year>2022</year>) <volume>23</volume>:<fpage>e13459</fpage>. doi: <pub-id pub-id-type="doi">10.1111/obr.13459</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalafi</surname> <given-names>M</given-names></name> <name><surname>Ravasi</surname> <given-names>AA</given-names></name> <name><surname>Soori</surname> <given-names>R</given-names></name> <name><surname>Moradi</surname> <given-names>M</given-names></name> <name><surname>Soleimani</surname> <given-names>M</given-names></name></person-group>. <article-title>The acute effects of high intensity interval training (HIIIT) on PGC-1&#x03B1; and FNDC5 genes expression in diabetic rats</article-title>. <source>J Sport Biosci</source>. (<year>2020</year>) <volume>12</volume>:<fpage>249</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.22059/jsb.2020.119643.902</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalafi</surname> <given-names>M</given-names></name> <name><surname>Symonds</surname> <given-names>ME</given-names></name></person-group>. <article-title>The impact of high intensity interval training on liver fat content in overweight or obese adults: a meta-analysis</article-title>. <source>Physiol Behav</source>. (<year>2021</year>) <volume>236</volume>:<fpage>113416</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.physbeh.2021.113416</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alimohammadi</surname> <given-names>S</given-names></name> <name><surname>Hobbenaghi</surname> <given-names>R</given-names></name> <name><surname>Javanbakht</surname> <given-names>J</given-names></name> <name><surname>Kheradmand</surname> <given-names>D</given-names></name> <name><surname>Mortezaee</surname> <given-names>R</given-names></name> <name><surname>Tavakoli</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>RETRACTED ARTICLE: protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation</article-title>. <source>Diagn Pathol</source>. (<year>2013</year>) <volume>8</volume>:<fpage>137</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1746-1596-8-137</pub-id>, PMID: <pub-id pub-id-type="pmid">23947821</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Budin</surname> <given-names>JT</given-names></name> <name><surname>Breene</surname> <given-names>WM</given-names></name> <name><surname>Putnam</surname> <given-names>DH</given-names></name></person-group>. <article-title>Some compositional properties of camelina (Camelina sativa L. Crantz) seeds and oils</article-title>. <source>J Am Oil Chem Soc</source>. (<year>1995</year>) <volume>72</volume>:<fpage>309</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1007/BF02541088</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirvani</surname> <given-names>H</given-names></name> <name><surname>Rahmati-Ahmadabad</surname> <given-names>S</given-names></name></person-group>. <article-title>Irisin interaction with adipose tissue secretions by exercise training and flaxseed oil supplement</article-title>. <source>Lipids Health Dis</source>. (<year>2019</year>) <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-019-0960-4</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname> <given-names>E</given-names></name> <name><surname>Iacono</surname> <given-names>A</given-names></name> <name><surname>Bianco</surname> <given-names>G</given-names></name> <name><surname>Autore</surname> <given-names>G</given-names></name> <name><surname>Cuzzocrea</surname> <given-names>S</given-names></name> <name><surname>Vajro</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats</article-title>. <source>J Nutr</source>. (<year>2009</year>) <volume>139</volume>:<fpage>905</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.108.101808</pub-id>, PMID: <pub-id pub-id-type="pmid">19321579</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koracevic</surname> <given-names>D</given-names></name> <name><surname>Koracevic</surname> <given-names>G</given-names></name> <name><surname>Djordjevic</surname> <given-names>V</given-names></name> <name><surname>Andrejevic</surname> <given-names>S</given-names></name> <name><surname>Cosic</surname> <given-names>V</given-names></name></person-group>. <article-title>Method for the measurement of antioxidant activity in human fluids</article-title>. <source>J Clin Pathol</source>. (<year>2001</year>) <volume>54</volume>:<fpage>356</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jcp.54.5.356</pub-id>, PMID: <pub-id pub-id-type="pmid">11328833</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nna</surname> <given-names>VU</given-names></name> <name><surname>Bakar</surname> <given-names>ABA</given-names></name> <name><surname>Mohamed</surname> <given-names>M</given-names></name></person-group>. <article-title>Malaysian propolis, metformin and their combination, exert hepatoprotective effect in streptozotocin-induced diabetic rats</article-title>. <source>Life Sci</source>. (<year>2018</year>) <volume>211</volume>:<fpage>40</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2018.09.018</pub-id>, PMID: <pub-id pub-id-type="pmid">30205096</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khani</surname> <given-names>M</given-names></name> <name><surname>Motamedi</surname> <given-names>P</given-names></name> <name><surname>Dehkhoda</surname> <given-names>MR</given-names></name> <name><surname>Dabagh Nikukheslat</surname> <given-names>S</given-names></name> <name><surname>Karimi</surname> <given-names>P</given-names></name></person-group>. <article-title>Effect of thyme extract supplementation on lipid peroxidation, antioxidant capacity, PGC-1&#x03B1; content and endurance exercise performance in rats</article-title>. <source>J Int Soc Sports Nutr</source>. (<year>2017</year>) <volume>14</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12970-017-0167-x</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jangale</surname> <given-names>NM</given-names></name> <name><surname>Devarshi</surname> <given-names>PP</given-names></name> <name><surname>Dubal</surname> <given-names>AA</given-names></name> <name><surname>Ghule</surname> <given-names>AE</given-names></name> <name><surname>Koppikar</surname> <given-names>SJ</given-names></name> <name><surname>Bodhankar</surname> <given-names>SL</given-names></name> <etal/></person-group>. <article-title>Dietary flaxseed oil and fish oil modulates expression of antioxidant and inflammatory genes with alleviation of protein glycation status and inflammation in liver of streptozotocin&#x2013;nicotinamide induced diabetic rats</article-title>. <source>Food Chem</source>. (<year>2013</year>) <volume>141</volume>:<fpage>187</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.03.001</pub-id>, PMID: <pub-id pub-id-type="pmid">23768346</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guven</surname> <given-names>A</given-names></name> <name><surname>Yavuz</surname> <given-names>O</given-names></name> <name><surname>Cam</surname> <given-names>M</given-names></name> <name><surname>Ercan</surname> <given-names>F</given-names></name> <name><surname>Bukan</surname> <given-names>N</given-names></name> <name><surname>Comunoglu</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Effects of melatonin on streptozotocin-induced diabetic liver injury in rats</article-title>. <source>Acta Histochem</source>. (<year>2006</year>) <volume>108</volume>:<fpage>85</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.acthis.2006.03.005</pub-id>, PMID: <pub-id pub-id-type="pmid">16714049</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gutch</surname> <given-names>M</given-names></name> <name><surname>Kumar</surname> <given-names>S</given-names></name> <name><surname>Razi</surname> <given-names>SM</given-names></name> <name><surname>Gupta</surname> <given-names>KK</given-names></name> <name><surname>Gupta</surname> <given-names>A</given-names></name></person-group>. <article-title>Assessment of insulin sensitivity/resistance</article-title>. <source>Indian J Endocrinol Metab</source>. (<year>2015</year>) <volume>19</volume>:<fpage>160</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.4103/2230-8210.146874</pub-id>, PMID: <pub-id pub-id-type="pmid">25593845</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname> <given-names>US</given-names></name> <name><surname>Lankinen</surname> <given-names>MA</given-names></name> <name><surname>de Mello</surname> <given-names>VD</given-names></name> <name><surname>Manninen</surname> <given-names>SM</given-names></name> <name><surname>Kurl</surname> <given-names>S</given-names></name> <name><surname>Pulkki</surname> <given-names>KJ</given-names></name> <etal/></person-group>. <article-title>Camelina sativa oil, but not fatty fish or lean fish, improves serum lipid profile in subjects with impaired glucose metabolism&#x2014;a randomized controlled trial</article-title>. <source>Mol Nutr Food Res</source>. (<year>2018</year>) <volume>62</volume>:<fpage>1700503</fpage>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.201700503</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J-x</given-names></name> <name><surname>Zhu</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>P-j</given-names></name> <name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Xu</surname> <given-names>Y-b</given-names></name></person-group>. <article-title>Effectiveness of high-intensity interval training on glycemic control and cardiorespiratory fitness in patients with type 2 diabetes: a systematic review and meta-analysis</article-title>. <source>Aging Clin Exp Res</source>. (<year>2019</year>) <volume>31</volume>:<fpage>575</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40520-018-1012-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30097811</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lepretti</surname> <given-names>M</given-names></name> <name><surname>Martucciello</surname> <given-names>S</given-names></name> <name><surname>Burgos Aceves</surname> <given-names>MA</given-names></name> <name><surname>Putti</surname> <given-names>R</given-names></name> <name><surname>Lionetti</surname> <given-names>L</given-names></name></person-group>. <article-title>Omega-3 fatty acids and insulin resistance: focus on the regulation of mitochondria and endoplasmic reticulum stress</article-title>. <source>Nutrients</source>. (<year>2018</year>) <volume>10</volume>:<fpage>350</fpage>&#x2013;<lpage>370</lpage>. doi: <pub-id pub-id-type="doi">10.3390/nu10030350</pub-id>, PMID: <pub-id pub-id-type="pmid">29538286</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeromson</surname> <given-names>S</given-names></name> <name><surname>Gallagher</surname> <given-names>IJ</given-names></name> <name><surname>Galloway</surname> <given-names>SDR</given-names></name> <name><surname>Hamilton</surname> <given-names>DL</given-names></name></person-group>. <article-title>Omega-3 fatty acids and skeletal muscle health</article-title>. <source>Mar Drugs</source>. (<year>2015</year>) <volume>13</volume>:<fpage>6977</fpage>&#x2013;<lpage>7004</lpage>. doi: <pub-id pub-id-type="doi">10.3390/md13116977</pub-id>, PMID: <pub-id pub-id-type="pmid">26610527</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname> <given-names>JFT</given-names></name> <name><surname>D&#x00E1;ttilo</surname> <given-names>M</given-names></name> <name><surname>de Mello</surname> <given-names>MT</given-names></name> <name><surname>Tufik</surname> <given-names>S</given-names></name> <name><surname>Antunes</surname> <given-names>HKM</given-names></name></person-group>. <article-title>High-intensity interval training attenuates insulin resistance induced by sleep deprivation in healthy males</article-title>. <source>Front Physiol</source>. (<year>2017</year>) <volume>8</volume>:<fpage>992</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2017.00992</pub-id>, PMID: <pub-id pub-id-type="pmid">29270126</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tejera</surname> <given-names>N</given-names></name> <name><surname>Vauzour</surname> <given-names>D</given-names></name> <name><surname>Betancor</surname> <given-names>MB</given-names></name> <name><surname>Sayanova</surname> <given-names>O</given-names></name> <name><surname>Usher</surname> <given-names>S</given-names></name> <name><surname>Cochard</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>A transgenic Camelina sativa seed oil effectively replaces fish oil as a dietary source of Eicosapentaenoic acid in mice</article-title>. <source>J Nutr</source>. (<year>2016</year>) <volume>146</volume>:<fpage>227</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.115.223941</pub-id>, PMID: <pub-id pub-id-type="pmid">26791554</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taranu</surname> <given-names>I</given-names></name> <name><surname>Gras</surname> <given-names>M</given-names></name> <name><surname>Pistol</surname> <given-names>GC</given-names></name> <name><surname>Motiu</surname> <given-names>M</given-names></name> <name><surname>Marin</surname> <given-names>DE</given-names></name> <name><surname>Lefter</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>&#x03C9;-3 PUFA rich camelina oil by-products improve the systemic metabolism and spleen cell functions in fattening pigs</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e110186</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0110186</pub-id>, PMID: <pub-id pub-id-type="pmid">25303320</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faghfouri</surname> <given-names>AH</given-names></name> <name><surname>Khajebishak</surname> <given-names>Y</given-names></name> <name><surname>Payahoo</surname> <given-names>L</given-names></name> <name><surname>Faghfuri</surname> <given-names>E</given-names></name> <name><surname>Alivand</surname> <given-names>M</given-names></name></person-group>. <article-title>PPAR-gamma agonists: potential modulators of autophagy in obesity</article-title>. <source>Eur J Pharmacol</source>. (<year>2021</year>) <volume>912</volume>:<fpage>174562</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174562</pub-id>, PMID: <pub-id pub-id-type="pmid">34655597</pub-id></citation></ref>
<ref id="ref56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shabani</surname> <given-names>M</given-names></name> <name><surname>Salesi</surname> <given-names>M</given-names></name> <name><surname>Daryanoosh</surname> <given-names>F</given-names></name></person-group>. <article-title>The effect of high-intensity interval training on the level of peroxisome proliferator-activated receptor gamma and PR domain containing 16 proteins in adipose tissue in overweight type 2 diabetic male Sprague-Dawley rats with diabetes</article-title>. <source>Pars Jahrom Univ Med Sci</source>. (<year>2018</year>) <volume>16</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.52547/jmj.16.4.1</pub-id></citation></ref>
<ref id="ref57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jafari</surname> <given-names>M</given-names></name></person-group>. <article-title>Eroxisome proliferator-activated receptors beta and gamma (PPAR&#x03B2; and PPAR&#x03B3;) genes expression following exercise trainings and high fat diet in male Wistar rats</article-title>. <source>J Pract Stud Biosci Sport</source>. (<year>2021</year>) <volume>9</volume>:<fpage>58</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.22077/jpsbs.2020.2947.1525</pub-id></citation></ref>
<ref id="ref58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cojocariu</surname> <given-names>R</given-names></name> <name><surname>Balmus</surname> <given-names>I</given-names></name> <name><surname>Lefter</surname> <given-names>R</given-names></name> <name><surname>Hritcu</surname> <given-names>L</given-names></name> <name><surname>Ababei</surname> <given-names>D</given-names></name> <name><surname>Ciobica</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Beneficial effects of Camelina sativa oil on behavioural (memory, anxiety, depression and social-related) manifestations and oxidative stress parameters in a mice model of irritable bowel syndrome</article-title>. <source>Biotechnol Lett</source>. (<year>2020</year>) <volume>25</volume>:<fpage>1532</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.25083/rbl/25.3/1532.1540</pub-id></citation></ref>
<ref id="ref59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaribeygi</surname> <given-names>H</given-names></name> <name><surname>Butler</surname> <given-names>AE</given-names></name> <name><surname>Barreto</surname> <given-names>GE</given-names></name> <name><surname>Sahebkar</surname> <given-names>A</given-names></name></person-group>. <article-title>Antioxidative potential of antidiabetic agents: a possible protective mechanism against vascular complications in diabetic patients</article-title>. <source>J Cell Physiol</source>. (<year>2019</year>) <volume>234</volume>:<fpage>2436</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcp.27278</pub-id>, PMID: <pub-id pub-id-type="pmid">30191997</pub-id></citation></ref>
<ref id="ref60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaribeygi</surname> <given-names>H</given-names></name> <name><surname>Sathyapalan</surname> <given-names>T</given-names></name> <name><surname>Atkin</surname> <given-names>SL</given-names></name> <name><surname>Sahebkar</surname> <given-names>A</given-names></name></person-group>. <article-title>Molecular mechanisms linking oxidative stress and diabetes mellitus</article-title>. <source>Oxidative Med Cell Longev</source>. (<year>2020</year>) <volume>2</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/8609213</pub-id></citation></ref>
<ref id="ref61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname> <given-names>J</given-names></name> <name><surname>Atalay</surname> <given-names>M</given-names></name></person-group>. <article-title>Protection against oxidative stress. Physiology and maintenance-volume II: enzymes: the biological catalysts of life</article-title>. <source>Nutr Diges</source>. (<year>2009</year>):<fpage>82</fpage>.</citation></ref>
<ref id="ref62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname> <given-names>AS</given-names></name> <name><surname>Hajduch</surname> <given-names>E</given-names></name> <name><surname>Litherland</surname> <given-names>GJ</given-names></name> <name><surname>Hundal</surname> <given-names>HS</given-names></name></person-group>. <article-title>Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways</article-title>. <source>J Biol Chem</source>. (<year>1999</year>) <volume>274</volume>:<fpage>36293</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.274.51.36293</pub-id>, PMID: <pub-id pub-id-type="pmid">10593919</pub-id></citation></ref>
<ref id="ref63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agil</surname> <given-names>A</given-names></name> <name><surname>El-Hammadi</surname> <given-names>M</given-names></name> <name><surname>Jim&#x00E9;nez-Aranda</surname> <given-names>A</given-names></name> <name><surname>Tassi</surname> <given-names>M</given-names></name> <name><surname>Abdo</surname> <given-names>W</given-names></name> <name><surname>Fern&#x00E1;ndez-V&#x00E1;zquez</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats</article-title>. <source>J Pineal Res</source>. (<year>2015</year>) <volume>59</volume>:<fpage>70</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jpi.12241</pub-id>, PMID: <pub-id pub-id-type="pmid">25904243</pub-id></citation></ref>
<ref id="ref64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swirski</surname> <given-names>FK</given-names></name> <name><surname>Libby</surname> <given-names>P</given-names></name> <name><surname>Aikawa</surname> <given-names>E</given-names></name> <name><surname>Alcaide</surname> <given-names>P</given-names></name> <name><surname>Luscinskas</surname> <given-names>FW</given-names></name> <name><surname>Weissleder</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata</article-title>. <source>J Clin Invest</source>. (<year>2007</year>) <volume>117</volume>:<fpage>195</fpage>&#x2013;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI29950</pub-id>, PMID: <pub-id pub-id-type="pmid">17200719</pub-id></citation></ref>
<ref id="ref65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>AL</given-names></name> <name><surname>Zhu</surname> <given-names>X</given-names></name> <name><surname>Rong</surname> <given-names>S</given-names></name> <name><surname>Shewale</surname> <given-names>S</given-names></name> <name><surname>Seo</surname> <given-names>J</given-names></name> <name><surname>Boudyguina</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2012</year>) <volume>32</volume>:<fpage>2122</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.112.253435</pub-id>, PMID: <pub-id pub-id-type="pmid">22814747</pub-id></citation></ref>
<ref id="ref66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shalhoub</surname> <given-names>J</given-names></name> <name><surname>Falck-Hansen</surname> <given-names>MA</given-names></name> <name><surname>Davies</surname> <given-names>AH</given-names></name> <name><surname>Monaco</surname> <given-names>C</given-names></name></person-group>. <article-title>Innate immunity and monocyte-macrophage activation in atherosclerosis</article-title>. <source>J Inflamm</source>. (<year>2011</year>) <volume>8</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1186/1476-9255-8-9</pub-id></citation></ref>
<ref id="ref67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarkson</surname> <given-names>PM</given-names></name> <name><surname>Thompson</surname> <given-names>HS</given-names></name></person-group>. <article-title>Antioxidants: what role do they play in physical activity and health?</article-title> <source>Am J Clin Nutr</source>. (<year>2000</year>) <volume>72</volume>:<fpage>637S</fpage>&#x2013;<lpage>46S</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/72.2.637S</pub-id></citation></ref>
<ref id="ref68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname> <given-names>T</given-names></name> <name><surname>Muraoka</surname> <given-names>I</given-names></name></person-group>. <article-title>Exercise-induced oxidative stress and the effects of antioxidant intake from a physiological viewpoint</article-title>. <source>Antioxidants</source>. (<year>2018</year>) <volume>7</volume>:<fpage>119</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox7090119</pub-id>, PMID: <pub-id pub-id-type="pmid">30189660</pub-id></citation></ref>
<ref id="ref69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogdanis</surname> <given-names>G</given-names></name> <name><surname>Stavrinou</surname> <given-names>P</given-names></name> <name><surname>Fatouros</surname> <given-names>I</given-names></name> <name><surname>Philippou</surname> <given-names>A</given-names></name> <name><surname>Chatzinikolaou</surname> <given-names>A</given-names></name> <name><surname>Draganidis</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Short-term high-intensity interval exercise training attenuates oxidative stress responses and improves antioxidant status in healthy humans</article-title>. <source>Food Chem Toxicol</source>. (<year>2013</year>) <volume>61</volume>:<fpage>171</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fct.2013.05.046</pub-id>, PMID: <pub-id pub-id-type="pmid">23747717</pub-id></citation></ref>
<ref id="ref70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname> <given-names>K</given-names></name> <name><surname>Bentley</surname> <given-names>D</given-names></name> <name><surname>Coutts</surname> <given-names>AJ</given-names></name></person-group>. <article-title>The role of oxidative, inflammatory and neuroendocrinological systems during exercise stress in athletes: implications of antioxidant supplementation on physiological adaptation during intensified physical training</article-title>. <source>Sports Med</source>. (<year>2015</year>) <volume>45</volume>:<fpage>453</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40279-014-0282-7</pub-id>, PMID: <pub-id pub-id-type="pmid">25398224</pub-id></citation></ref>
<ref id="ref71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallsworth</surname> <given-names>K</given-names></name> <name><surname>Thoma</surname> <given-names>C</given-names></name> <name><surname>Hollingsworth</surname> <given-names>KG</given-names></name> <name><surname>Cassidy</surname> <given-names>S</given-names></name> <name><surname>Anstee</surname> <given-names>QM</given-names></name> <name><surname>Day</surname> <given-names>CP</given-names></name> <etal/></person-group>. <article-title>Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial</article-title>. <source>Clin Sci (Lond)</source>. (<year>2015</year>) <volume>129</volume>:<fpage>1097</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.1042/CS20150308</pub-id>, PMID: <pub-id pub-id-type="pmid">26265792</pub-id></citation></ref>
<ref id="ref72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname> <given-names>S</given-names></name> <name><surname>So</surname> <given-names>R</given-names></name> <name><surname>Shida</surname> <given-names>T</given-names></name> <name><surname>Matsuo</surname> <given-names>T</given-names></name> <name><surname>Kim</surname> <given-names>B</given-names></name> <name><surname>Akiyama</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>43029</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep43029</pub-id>, PMID: <pub-id pub-id-type="pmid">28223710</pub-id></citation></ref>
<ref id="ref73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname> <given-names>NC</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Rector</surname> <given-names>RS</given-names></name> <name><surname>Parks</surname> <given-names>EJ</given-names></name> <name><surname>Ibdah</surname> <given-names>JA</given-names></name> <name><surname>Kanaley</surname> <given-names>JA</given-names></name></person-group>. <article-title>Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity &#x2013; a randomized trial</article-title>. <source>Metabolism</source>. (<year>2018</year>) <volume>78</volume>:<fpage>128</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.metabol.2017.08.012</pub-id></citation></ref>
<ref id="ref74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdelbasset</surname> <given-names>WK</given-names></name> <name><surname>Tantawy</surname> <given-names>SA</given-names></name> <name><surname>Kamel</surname> <given-names>DM</given-names></name> <name><surname>Alqahtani</surname> <given-names>BA</given-names></name> <name><surname>Soliman</surname> <given-names>GS</given-names></name></person-group>. <article-title>A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease</article-title>. <source>Medicine (Baltimore)</source>. (<year>2019</year>) <volume>98</volume>:<fpage>e14918</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000014918</pub-id>, PMID: <pub-id pub-id-type="pmid">30896648</pub-id></citation></ref>
<ref id="ref75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Omidifar</surname> <given-names>A</given-names></name> <name><surname>Shirvani</surname> <given-names>H</given-names></name> <name><surname>Taheri</surname> <given-names>RA</given-names></name> <name><surname>Gorgani-Firouzjae</surname> <given-names>S</given-names></name> <name><surname>Delfan</surname> <given-names>M</given-names></name> <name><surname>Kalaki-Jouybari</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Protective effects of HIIT vs. CET exercise training on high-fat-high-fructose diet-induced hyperglycemia, hyperlipidemia, and histopathology of liver in rats: regulation of SIRT1/PGC-1&#x03B1;</article-title>. <source>Sport Sci. Health</source>. (<year>2021</year>) <volume>17</volume>:<fpage>707</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11332-021-00736-9</pub-id></citation></ref>
<ref id="ref76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamasaki</surname> <given-names>H</given-names></name></person-group>. <article-title>Perspectives on interval exercise interventions for non-alcoholic fatty liver disease</article-title>. <source>Medicines (Basel)</source>. (<year>2019</year>) <volume>6</volume>:<fpage>83</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.3390/medicines6030083</pub-id></citation></ref>
<ref id="ref77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scorletti</surname> <given-names>E</given-names></name> <name><surname>Byrne</surname> <given-names>CD</given-names></name></person-group>. <article-title>Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease</article-title>. <source>Annu Rev Nutr</source>. (<year>2013</year>) <volume>33</volume>:<fpage>231</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-nutr-071812-161230</pub-id></citation></ref>
<ref id="ref78"><label>78.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>R</given-names></name> <name><surname>Zhou</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Effects of Omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis</article-title>. <source>Gastroenterol Res Pract</source>. (<year>2016</year>) <volume>2016</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/1459790</pub-id></citation></ref>
<ref id="ref79"><label>79.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makni</surname> <given-names>M</given-names></name> <name><surname>Fetoui</surname> <given-names>H</given-names></name> <name><surname>Gargouri</surname> <given-names>N</given-names></name> <name><surname>Garoui</surname> <given-names>EM</given-names></name> <name><surname>Jaber</surname> <given-names>H</given-names></name> <name><surname>Makni</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Hypolipidemic and hepatoprotective effects of flax and pumpkin seed mixture rich in &#x03C9;-3 and &#x03C9;-6 fatty acids in hypercholesterolemic rats</article-title>. <source>Food Chem Toxicol</source>. (<year>2008</year>) <volume>46</volume>:<fpage>3714</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fct.2008.09.057</pub-id>, PMID: <pub-id pub-id-type="pmid">18938206</pub-id></citation></ref>
<ref id="ref80"><label>80.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bati</surname> <given-names>B</given-names></name> <name><surname>Celik</surname> <given-names>I</given-names></name> <name><surname>Dogan</surname> <given-names>A</given-names></name></person-group>. <article-title>Determination of hepatoprotective and antioxidant role of walnuts against ethanol-induced oxidative stress in rats</article-title>. <source>Cell Biochem Biophys</source>. (<year>2015</year>) <volume>71</volume>:<fpage>1191</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12013-014-0328-3</pub-id>, PMID: <pub-id pub-id-type="pmid">25391888</pub-id></citation></ref>
<ref id="ref81"><label>81.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Apoorva</surname> <given-names>N</given-names></name> <name><surname>Rao</surname> <given-names>RR</given-names></name> <name><surname>Shenoy</surname> <given-names>PJ</given-names></name> <name><surname>Sindhu</surname> <given-names>H</given-names></name> <name><surname>Teerthanath</surname> <given-names>S</given-names></name></person-group>. <article-title>Salvia hispanica (chia) seeds afford hepatoprotection against isoniazid and rifampicin induced toxicity in a murine model</article-title>. <source>Res J Pharm Technol</source>. (<year>2020</year>) <volume>13</volume>:<fpage>4805</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.5958/0974-360X.2020.00845.8</pub-id></citation></ref>
</ref-list>
</back>
</article>